This educational guide is based on the linked primary sources. It is not a Court publication, is not affiliated with the Court, and is not legal advice.
In brief
Overview
The Supreme Court granted certiorari on a limited question whether a securities‑fraud complaint that relies only on a few adverse drug‑event reports can establish materiality and scienter without statistical significance.
According to Jonathan Hacker (Petitioners), according to Jonathan Hacker (Petitioners), petitioners argue that anecdotal adverse‑event reports are insufficient to establish reliable facts about a drug’s safety, especially when only a handful of reports exist among millions of units sold.
Respondents, supported by the United States amicus, contend that materiality should be judged by whether a reasonable investor would view the information as meaningfully altering the total mix of information, not by a categorical rule requiring statistical significance.
Background and question before the Court
The Supreme Court’s limited question is whether a complaint that alleges only adverse reports can prove materiality and scienter without showing statistical importance.
What each side argues
Petitioner (Matrixx Initiatives, Inc.)
According to Jonathan Hacker (Petitioners), according to Jonathan Hacker (Petitioners), all drug companies receive anecdotal reports of adverse health events, but such reports alone do not establish reliable facts about a drug’s safety.
According to Matrixx, matrixx proposes a rule that would apply only in the hypothetical scenario where investors rely solely on the number of adverse event reports in pleading securities fraud.
According to Mr. Hacker, the material omission is that adverse event reports told Matrixx that Zicam causes anosmia, which the company allegedly failed to disclose.
According to Mr. Hacker, there is no allegation that consumer product sales were affected, and in fact they were not.
Respondent (James Siracusano)
According to Mr. Shah, the Solicitor General argued that a safe‑harbor exists for companies that include meaningful cautionary language in forward‑looking statements, shielding them from liability.
What happened at oral argument
Justice Ginsburg asked whether the record shows that there were no other complaints beyond the ones identified.
Justice Breyer also asked whether the complaint shows a “strong inference of scienter” or merely a borderline situation.
What the Court decided
Why it matters
According to United States, under securities law, information is material if a reasonable investor would view it as meaningfully altering the total mix of information.
Terms to know
No glossary terms are available for this guide.
Primary sources
Read the source materials on the official site or open the immutable repository copy used for this guide.
- b6aef409d88853a17623-r1-2bc59de7d107515e.pdforal argument transcript
Guide generated September 23, 2026. Automated validation accepted this version.